Clinical trial
Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation, Primary Intention (EMMA Study)
NCT05336526 is registered in ClinicalTrials.gov with Symatese Aesthetics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation, Primary Intention (EMMA Study)
- Lead sponsor
- Symatese Aesthetics
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 18, 2022
- Completion date
- September 30, 2025
- Enrollment
- 88 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
bilateral breast augmentation